Received Dec 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | RA |
I am sill experiencing muscle and joint pain, which I did not have before the vaccine; I am sill experiencing muscle and joint pain, which I did not have before the vaccine; This is a spontaneous report received from a Consumer or other non HCP. A 72-year-old female patient (not pregnant) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 14Oct2025 at 09:30 as dose 1, single (Batch/Lot number: unknown) at the age of 72 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Multiple Myeloma" (unspecified if ongoing); "Drug allergy" (unspecified if ongoing), notes: Unspecified drug. The patient took concomitant medications. The following information was reported: MYALGIA (non-serious), ARTHRALGIA (non-serious) all with onset 17Oct2025, outcome "not recovered" and all described as "I am sill experiencing muscle and joint pain, which I did not have before the vaccine". Therapeutic measures were not taken as a result of myalgia, arthralgia. Additional information: Concomitant medication included,"Daratumabab + Lenalidomide" started on 17Mar2025. Patient did not receive any other vaccines on the same date as the vaccine(s) for which was reporting. She did not receive any other vaccines within 4 weeks prior to the vaccine(s) for which was reporting. She was taking any other medications within 2 weeks of the event starting: Yes. The information on the batch/lot number for BNT162b2 omicron (lp.8.1) will be requested and submitted if and when received.
Medical History/Concurrent Conditions: Drug allergy (Unspecified drug.); Multiple myeloma